Nothing New under the Sun: Clozapine Rechallenge following a Life-Threatening Medical Event in a Patient with Psychiatric Illness and Developmental Disability

REFERENCES

• Shedlack KJ. Creating a continuum of intensive psychiatric ser- vices for individuals with dual diagnosis: the Massachusetts ex- perience. II—partial hospitalization. Natl Assoc Dual Diagnosis Bull 2001;4: 1:5–6.
   Google Scholar
• Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993;77:185–202.
   PubMed Web of Science ®Google Scholar
• Levenson JL. Neuroleptic malignant syndrome. Am J Psychia- try 1985;142:1137–45.
   PubMed Web of Science ®Google Scholar
• Pope HG, Keck PE, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 1986;143:1227–33.
   PubMed Web of Science ®Google Scholar
• Caroff SN, Mann SC, Campbell EC. Atypical antipsychotics and neuroleptic malignant syndrome. Psychiatr Ann 2000;30:314– 21.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
   Google Scholar
• Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic ma- lignant syndrome: a review. Psychiatr Serv 1998;49:1163– 72.
   Google Scholar
• Hyman SE. Toxic side effects of psychotropic medications and their management. In: Hyman SE, Tesar GE, eds. Man- ual of psychiatric emergencies. 3rd ed. Boston: Little, Brown, 1994:204–17.
   Google Scholar
• Cohen R, Moelleken BRW. Disorders due to physical agents: disorders due to heat. In: Tierney LM, Papadakis MA, McPhee SJ, eds. Current medical diagnosis and treatment. 42nd ed. New York, Lange Medical Books/McGraw-Hill, 2003:1536– 43.
   Google Scholar
• Urbano-Brown A, Proulx RP, Schwartz GR. Heat stress dis- eases. In: Schwartz GR, ed. Principles and practice of emer- gency medicine. 4th ed. Baltimore, MD: Williams & Wilkins, 1999:1594–1601.
   Google Scholar
• Mann SC, Caroff SN, Bleier HR, Welz WK, Kling MA, Hayashida M. Lethal catatonia. Am J Psychiatry 1986;143:1374–81.
   PubMed Web of Science ®Google Scholar
• Petrides G, Fink M. The catatonic syndrome: a review of recent clinical experience. In: Andrade C. Advances in Psychiatry. New Delhi: Oxford University Press, 2000:26–44.
   Google Scholar
• Fink M. Catatonia: syndrome or schizophrenia subtype? Recognition and treatment. J Neural Transm 2001;108:637– 44.
   Google Scholar
• Pope HG Jr, Cole JO, Choras PT, Fulwiler CE. Apparent neu- roleptic malignant syndrome with clozapine and lithium. J Nerv Ment Dis 1986;174:493–5.
   PubMedGoogle Scholar
• Tham JC, Dickson RA. Clozapine-induced fevers and 1-year clozapine discontinuation rate. J Clin Psychiatry 2002;63:880– 4.
   Google Scholar
• Shalev A, Harmesh H, Munitz H. The role of external heat load in triggering the neuroleptic malignant syndrome. Am J Psy- chiatry 1988;145:110–1.
   PubMedGoogle Scholar
• Hermesh H, Shiloh R, Epstein Y, Manaim H, Weizman A, Munitz H. Heat intolerance in patients with chronic schizophre- nia maintained with antipsychotic drugs. Am J Psychiatry 2000;1257:1327–9.
   Google Scholar
• Lazarus A. Differentiating neuroleptic-related heatstroke from neuroleptic malignant syndrome. Psychosomatics 1989;30:454– 6.
   Google Scholar
• Charlot LR, Abend S, Silka VR, Kuropatkin B, Garcia O, Bolduc M, et al. A short stay inpatient psychiatric unit for adults with developmental disabilities. In: Jacobsen J, Mulick J, Holburn S, eds. Contemporary dual diagnosis: MH/MR service models. Vol. 1: Residential and day services. Kingston, NY: NADD Press, 2002:35–55.
   Google Scholar
• McGugan EA. Hyperpyrexia in the emergency department. Emerg Med (Fremantle) 2001;13:116–20.
   PubMedGoogle Scholar
• Karagianis JL, Phillips LC, Hogan KP, LeDrew KK. Clozapine- associated neuroleptic syndrome: two new cases and a review of the literature. Ann Pharmacother 1999;5:623–30.
   Google Scholar
• Silka VR, Charlot LR. Neuroleptic withdrawal syndrome and cardiac risk of neuroleptics. In: Proceedings of the 19th Annual Conference, National Association for the Dually Diagnosed, Denver, CO, USA, October 2002.
   Google Scholar
• Aman MG, Singh NN. Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and methylphenidate treatment. J Ment Defic Res 1985;29:187–95.
   PubMedGoogle Scholar
• Illing M, Ancill R. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of pre- vious NMS. Can J Psychiatry 1996;41:258.
   PubMed Web of Science ®Google Scholar
• Weller M, Kornhuber J. Clozapine rechallenge after an episode of ‘neuroleptic malignant syndrome.’ Br J Psychiatry 1992;161:855–6.
   Google Scholar
• Rogers v. Commissioner of the Department of Mental Health, 458 N.E.2d 308 (Mass. 1983).
   Google Scholar
• Mikkelsen EJ, McKenna L. Psychopharmacologic algorithms for adults with developmental disabilities and difficult-to- diagnose behavioral disorders. Psychiatr Ann 1999;29:302–14.
   Google Scholar